With unparalleled access to data, intelligent technologies, and advanced analytics – all built and backed by deep RCM experts – we help leading providers transform their approach to financial performance and patient care, today and tomorrow.

R1 RCM is a leading provider of technology-enabled revenue cycle management services for hospitals, health systems and physician groups.

Nov 19, 2024 · Joe joined R1 in June 2013 and served as President, Chief Executive Officer from 2016-2023 and as member of the Board of Directors presently. To this role, Joe brings 20+ years of management experience and will drive continued operational excellence, technology leadership and value creation for R1’s client partners.

R1’s global footprint brings together experienced and diverse talent, onsite management and purpose-built technology that enables us to scale our solutions to serve a diverse range of clients of healthcare providers.

The R1 Platform is a data powerhouse that integrates and unifies millions of clinical, financial and patient datapoints to enable accurate, reliable and secure information exchange, across all data sources.

R1 Ranks BEST in KLAS for Ambulatory RCM Services (EHR-Agnostic) for Fifth Straight Year Read more

MURRAY, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to be acquired by investment funds ...

Jan 24, 2018 · CHICAGO--(BUSINESS WIRE)-- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management (RCM) and physician advisory services to healthcare providers, today announced an expanded 10-year agreement with longstanding customer Intermountain Healthcare to be the exclusive RCM provider across all Intermountain ...

Under the terms of the securities purchase agreement governing the terms of the acquisition, R1 acquired Acclara for $675 million in cash and a warrant to purchase up to 12.2 million shares of R1 stock at a strike price of $10.52, subject to a three-year lock-up.

R1 has been recognized by KLAS yet again, earning the top distinction in the Ambulatory RCM Services (EHR-Agnostic) category for an unprecedented fifth year in a row. Winning the Best in KLAS award once again highlights R1’s unwavering dedication to providing outstanding ambulatory RCM solutions.